China’s Sinovac reports mixed findings in early coronavirus vaccine trials - The Washington Post

Study found the vaccine candidate produced a quick immune response but lower levels of antibodies than in recovered coronavirus patients. https://www.washingtonpost.com/world/asia_pacific/coronavirus-vaccine-china-trial-sinovac/2020/11/18/4e47b0fe-294f-11eb-9c21-3cc501d0981f_story.html